Science ❯ Biotechnology

Therapeutics

Cancer Treatment Monoclonal Antibodies Antibody Engineering Superkines Antibody Therapeutics Molecular Biology Cancer Therapies mRNA Technologies Chemical Research Early Stage Companies Protein Engineering Preclinical Testing AI in Drug Development Antibody Design Regenerative Medicine Autoimmune Diseases Cancer Research Clinical Trials Advanced Therapies Cellular Therapies Neonatal Therapies Gene Therapy Drug Delivery Immunology

Boxer Capital Buys 1.24 Million Vir Biotechnology Shares

The buy underscores improving sentiment, with promising trial data plus a pending Astellas payment bolstering the case.

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

Bristol Myers, Janux Strike Exclusive Deal on Tumor-Activated T-Cell Engager

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund